Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

1,830.00p
   
  • Change Today:
    -70.00p
  • 52 Week High: 3,750.00p
  • 52 Week Low: 1,800.00p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 5,360
  • Market Cap: £95.61m

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Independent Non-Executive Director: Joanne (Jo) Pisani
Independent Non-Executive Director: Nicholas (Nick) John McCooke
Non-Executive Dir:

Contact Details

Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Website: http://www.bioventix.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B4QVDF07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,830.00p
Change Today -70.00p
% Change -3.68 %
52 Week High 3,750.00p
52 Week Low 1,800.00p
Volume 5,360
Shares Issued 5.22m
Market Cap £95.61m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 06-Nov-25 10-Apr-25
Paid 21-Nov-25 25-Apr-25
Amount 80.00p 70.00p

Trades for 05-Dec-2025

Time Volume / Share Price
16:27 650 @ 1,830.00p
16:37 150 @ 1,830.00p
16:37 150 @ 1,830.00p
16:35 300 @ 1,830.00p
16:35 300 @ 1,830.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page